We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $26B
1-Year Est. Return 58.24%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+58.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$26B
AUM Growth
+$1.7B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,181
New
Increased
Reduced
Closed

Top Buys

1 +$621M
2 +$467M
3 +$205M
4
VLO icon
Valero Energy
VLO
+$150M
5
SOFI icon
SoFi Technologies
SOFI
+$136M

Top Sells

1 +$599M
2 +$468M
3 +$306M
4
AAPL icon
Apple
AAPL
+$280M
5
MU icon
Micron Technology
MU
+$260M

Sector Composition

1 Technology 15.17%
2 Financials 9.68%
3 Industrials 7.3%
4 Healthcare 6.5%
5 Energy 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXF icon
3326
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.81B
-61,934
PYXS icon
3327
Pyxis Oncology
PYXS
$106M
-39,649
PYPL icon
3328
PayPal
PYPL
$35.9B
-457,063
PZT icon
3329
Invesco New York AMT-Free Municipal Bond ETF
PZT
$135M
-11,266
PZZA icon
3330
Papa John's
PZZA
$1.04B
-22,020
QCOM icon
3331
Qualcomm
QCOM
$202B
0
QID icon
3332
ProShares UltraShort QQQ
QID
$275M
-169,234
QIPT
3333
DELISTED
Quipt Home Medical
QIPT
-18,299
QMAR icon
3334
FT Vest Growth-100 Buffer ETF March
QMAR
$547M
-34,817
QSI icon
3335
Quantum-Si Incorporated
QSI
$206M
-104,292
QUAD icon
3336
Quad
QUAD
$391M
-11,872
QURE icon
3337
uniQure
QURE
$1.69B
-310,050
QVML icon
3338
Invesco S&P 500 QVM Multi-factor ETF
QVML
$1.59B
-5,820
RA
3339
Brookfield Real Assets Income Fund
RA
$703M
-11,490
RAMP icon
3340
LiveRamp
RAMP
$2.26B
-16,386
RCKT icon
3341
Rocket Pharmaceuticals
RCKT
$284M
-109,797
RCL icon
3342
Royal Caribbean
RCL
$72.1B
0
RDNT icon
3343
RadNet
RDNT
$4.57B
0
RDY icon
3344
Dr. Reddy's Laboratories
RDY
$11.1B
-65,214
REFI
3345
Chicago Atlantic Real Estate Finance
REFI
$241M
-16,535
REGN icon
3346
Regeneron Pharmaceuticals
REGN
$63.1B
0
RELY icon
3347
Remitly
RELY
$3.8B
-1,201,439
REPL icon
3348
Replimune Group
REPL
$699M
-183,592
RES icon
3349
RPC Inc
RES
$1.58B
-268,313
REVB icon
3350
Revelation Biosciences
REVB
$4.03M
-3,830